Adam Webb — Non Executive Chairman
Adam qualified and practised as a solicitor with Slaughter and May, and moved into merchant banking with Samuel Montagu & Co and then Morgan Grenfell. He was appointed head of CIBC/Wood Gundy’s corporate finance/broking operations in London and Europe, and held the same position with Société Généralé, as head of European mergers and acquisitions. He established and ran Adam & Partners Limited and Navigator Corporate Finance Limited as independent authorised financial advisory firms, providing takeover advice to UK public companies and dealing with private equity funds.
Daan van den Noort (58) — Non Executive Director
Daan is an experienced investment director having previously been a general practitioner until 1988, when he joined the pharmaceutical industry as Marketing Manager of Pharmacia. In 1994 he joined Genentech Inc. as Managing Director The Netherlands. From 1999 he joined Ferring Geneesmiddelen as General Manager and in 2001 he joined a venture capital fund, Biotech Turnaround Fund (“BTF”). In 2010 Daan set up DvDNA Consult an advisory firm based in Amsterdam providing services in the field of finance, biotechnology, business development and management. Daan serves as an external advisor for KPMG Meijburg & Co and Mercurius Investments BV. He serves as director for Bioseutica Lugano, Pharmacell NL, Zenith International Reserves Limited, Zenith International Bond Funds Limited and Hume Global Investors PCC Limited.